buserelin has been researched along with Menopause in 46 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 24 (52.17) | 18.7374 |
| 1990's | 22 (47.83) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Jong, FH; Klijn, JG | 1 |
| Alexieva-Figusch, J; Blankenstein, MA; Blonk-van der Wijst, J; de Jong, FH; Docter, R; Klijn, JG; Lamberts, SW | 1 |
| Jacobs, HS; Lightman, SL; Maguire, AK | 1 |
| Aliaga, R; Cano, A | 1 |
| Grunberg, SM | 1 |
| Nakamura, Y; Yoshimura, Y | 1 |
| Abu-Musa, A; Hannoun, A; Karam, K; Khalil, A; Masaad, Z | 1 |
| Bianco, AR; Blamey, RW; Jonat, W; Kaufmann, M; Namer, M | 1 |
| Coombes, RC; Dowsett, M; Stein, RC | 1 |
| Aoki, Y; Honma, S; Kanazawa, K; Kodama, S; Kurabayashi, T; Tanaka, K; Yoshiya, N | 1 |
| Barnes, JF; Farish, E; Fletcher, CD; Gray, CE; Hart, DM; Mack, A | 1 |
| Aakvaag, A; Johannessen, DC; Lien, EA; Lønning, PE | 1 |
| Bates, K; Blamey, RW; Nicholson, RI; Pearson, D; Robertson, JF | 1 |
| Crosignani, PG; Maini, MC; Negri, E; Ragni, G | 1 |
| Carpano, S; Di Lauro, L; Lopez, M; Veltri, E; Vici, P | 1 |
| Blamey, RW; Bouzubar, N; Dixon, AR; Ellis, IO; McClelland, R; Nicholson, RI; Robertson, JF; Walker, KJ | 1 |
| Bianco, AR; Calabresi, F; De Placido, S; Fiorentino, M; Fosser, V; Lenti, R; Lopez, M; Perrone, F; Rosso, R; Sismondi, PG | 1 |
| Ando, M; Nakamura, Y; Suzuki, M; Ubukata, Y; Yamada, H; Yoshimura, Y | 1 |
| Abbate, R; Bruni, V; Cirri, R; Coppo, M; Pinto, S; Rosati, D | 1 |
| Ito, M; Okamura, H; Sakoda, Y | 1 |
| Ando, M; Maruyama, K; Nakamura, Y; Nanno, T; Suzuki, M; Takahashi, K; Ubukata, Y; Yamada, H; Yoshimura, Y | 1 |
| Ding, YQ; Huhtaniemi, I; Jaakkola, T; Kellokumpu-Lehtinen, P; Martikainen, H; Rönnberg, L; Tapanainen, J; Valavaara, R | 1 |
| Bouzubar, N; Davies, P; Gee, JM; Nicholson, RI; Rushmere, NK; Walker, KJ; Wills, RJ | 1 |
| Coombes, RC; Dowsett, M; Ford, HT; Gazet, JC; Hedley, A; Stein, RC | 1 |
| Blamey, RW; Dixon, AR; Jackson, L; Nicholson, RI; Robertson, JF; Walker, KJ | 1 |
| Albrecht, M; Eiermann, W; Hilfrich, J; Jänicke, F; Jonat, W; Kaufmann, M; Kleeberg, U; Kreienberg, R; Schmid, H; Weitzel, HK | 1 |
| Cantwell, BM; Carmichael, J; Dowsett, M; Harris, AL | 2 |
| Anderson, ED; Chetty, U; Forrest, AP; Hawkins, RA; Levack, PA | 1 |
| Nicholson, RI; Walker, KJ | 1 |
| Cantwell, BM; Dowsett, M; Harris, AL | 1 |
| Cheson, BD | 1 |
| Astone, A; Barone, C; Cassano, A; Garufi, C; Noviello, MR; Pietrantonio, F | 1 |
| Barni, S; Cattaneo, G; Crispino, S; Lissoni, P; Tancini, G | 1 |
| Blamey, RW; Dyas, J; Nicholson, RI; Plowman, PN; Turkes, A; Walker, KJ; Williams, M | 1 |
| Blamey, RW; Nicholson, RI; Turkes, A; Walker, KJ; Williams, MR | 1 |
| Nicholson, RI; Plowman, PN; Walker, KJ | 1 |
| Cantwell, B; Dowsett, M; Harris, AL; Jeffcoate, SL; Lal, A | 1 |
| Blamey, RW; Ellis, IO; Elston, CW; Nicholson, RI; Robertson, JF; Williamson, K | 1 |
| Harvey, H; Lipton, A; Manni, A; Max, D; Santen, R | 1 |
| Hesp, R; Katz, D; Matta, WH; Shaw, RW | 1 |
| Evans, R; Hesp, R; Matta, WH; Shaw, RW | 1 |
| Coombes, RC; Harland, SJ; Lister, TA; Malpas, JS; Powles, T; Waxman, JH; Wrigley, PF | 1 |
| Fraser, HM; Howie, PW; Kerr-Wilson, RH; McNeilly, AS; Sandow, J; Shaw, RW | 1 |
| Becher, R; Höffken, K; Miller, AA; Miller, B; Schmidt, CG | 1 |
| Blankenstein, MA; de Jong, FH; Klijn, JG; Lamberts, SW | 1 |
4 review(s) available for buserelin and Menopause
| Article | Year |
|---|---|
Role of antiprogestational therapy for meningiomas.
Topics: Buserelin; Clinical Trials as Topic; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Double-Blind Method; Estradiol; Estrogen Antagonists; Female; Glucocorticoids; Gonadal Steroid Hormones; Humans; Male; Meningeal Neoplasms; Meningioma; Menopause; Mifepristone; Neoplasms, Hormone-Dependent; Pituitary-Adrenal System; Progesterone; Randomized Controlled Trials as Topic; Thyroid Gland | 1994 |
Aromatization inhibition alone or in combination with GnRH agonists for the treatment of premenopausal breast cancer patients.
Topics: Androstenedione; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Buserelin; Estrogens; Female; Goserelin; Humans; Menopause | 1992 |
Gn-RH agonists in breast and gynaecologic cancer treatment.
Topics: Animals; Breast Neoplasms; Buserelin; Female; Follicle Stimulating Hormone; Genital Neoplasms, Female; Goserelin; Humans; Luteinizing Hormone; Menopause; Rats; Rats, Inbred Strains | 1989 |
[Hormone therapy of metastatic breast carcinoma].
Topics: Aminoglutethimide; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Buserelin; Female; Gonadotropin-Releasing Hormone; Humans; Menopause; Neoplasm Metastasis | 1985 |
10 trial(s) available for buserelin and Menopause
| Article | Year |
|---|---|
Anti-tumor and endocrine effects of chronic LHRH agonist treatment (Buserelin) with or without tamoxifen in premenopausal metastatic breast cancer.
Topics: Adult; Breast Neoplasms; Buserelin; Clinical Trials as Topic; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Menopause; Middle Aged; Neoplasm Metastasis; Tamoxifen | 1984 |
Treatment of uterine leiomyomas in perimenopausal women with gonadotropin-releasing hormone agonists.
Topics: Administration, Intranasal; Adult; Buserelin; Estradiol; Female; Follicle Stimulating Hormone; Hemoglobins; Humans; Leiomyoma; Luteinizing Hormone; Menopause; Middle Aged; Ultrasonography; Uterine Neoplasms | 1993 |
Goserelin depot in the treatment of premenopausal advanced breast cancer.
Topics: Adult; Breast Neoplasms; Buserelin; Delayed-Action Preparations; Estradiol; Female; Goserelin; Humans; Luteinizing Hormone; Menopause; Menstruation; Middle Aged | 1992 |
LH-RH analogue Zoladex in the treatment of pre- and perimenopausal women with metastatic breast cancer (results of the Italian Cooperative Study).
Topics: Adult; Breast Neoplasms; Buserelin; Chemotherapy, Adjuvant; Delayed-Action Preparations; Drug Evaluation; Estradiol; Female; Follicle Stimulating Hormone; Goserelin; Humans; Life Tables; Luteinizing Hormone; Menopause; Middle Aged | 1991 |
Treatment of uterine leiomyomata with a luteinizing hormone-releasing hormone agonist: the possibility of nonsurgical management in selected perimenopausal women.
Topics: Adult; Bone and Bones; Buserelin; Estradiol; Female; Follicle Stimulating Hormone; Humans; Leiomyoma; Luteinizing Hormone; Menopause; Middle Aged; Random Allocation; Retrospective Studies; Uterine Neoplasms; Uterus | 1991 |
Changes in thromboxane A2 generation and plasma lipid pattern in pseudomenopause induced by gonadotropin releasing hormone (GnRH) analogue buserelin.
Topics: Adult; Blood Coagulation; Blood Platelets; Buserelin; Female; Gonadal Steroid Hormones; Humans; Leiomyoma; Lipids; Menopause; Middle Aged; Thromboxane A2; Uterine Neoplasms | 1991 |
The clinical and endocrine effects of 4-hydroxyandrostenedione alone and in combination with goserelin in premenopausal women with advanced breast cancer.
Topics: Adult; Androstenedione; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Buserelin; Female; Goserelin; Humans; Menopause; Middle Aged; Ovariectomy | 1990 |
Goserelin, a depot gonadotrophin-releasing hormone agonist in the treatment of premenopausal patients with metastatic breast cancer. German Zoladex Trial Group.
Topics: Adult; Breast Neoplasms; Buserelin; Delayed-Action Preparations; Female; Goserelin; Humans; Injections, Subcutaneous; Menopause; Middle Aged; Multicenter Studies as Topic; Neoplasm Metastasis; Receptors, Estrogen; Receptors, Progesterone; Remission Induction | 1989 |
Reversible trabecular bone density loss following induced hypo-oestrogenism with the GnRH analogue buserelin in premenopausal women.
Topics: Adult; Bone and Bones; Buserelin; Endometriosis; Female; Femur; Humans; Lumbar Vertebrae; Menopause; Minerals; Ovary | 1988 |
LHRH-agonist treatment in clinical and experimental human breast cancer.
Topics: Administration, Intranasal; Breast Neoplasms; Buserelin; Cell Line; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Megestrol; Megestrol Acetate; Menopause; Menstrual Cycle; Progesterone; Prolactin; Receptors, Estradiol; Tamoxifen | 1985 |
32 other study(ies) available for buserelin and Menopause
| Article | Year |
|---|---|
Treatment with a luteinising-hormone-releasing-hormone analogue (buserelin) in premenopausal patients with metastatic breast cancer.
Topics: Adult; Anovulation; Breast Neoplasms; Buserelin; Estradiol; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Menopause; Middle Aged; Neoplasm Metastasis | 1982 |
Down-regulation of gonadotrophin secretion in postmenopausal women by a superactive LHRH analogue: lack of effect on menopausal flushing.
Topics: Adult; Buserelin; Climacteric; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Hormones; Humans; Luteinizing Hormone; Menopause; Middle Aged | 1982 |
Characteristics of urinary luteinizing hormone (LH) during the induction of LH surges of different magnitude in blood.
Topics: Adult; Buserelin; Estradiol; Estrogen Replacement Therapy; Female; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Menopause; Middle Aged; Ovulation Detection; Progesterone; Radioimmunoassay; Reproducibility of Results; Sensitivity and Specificity; Time Factors | 1995 |
Artificial endometrial preparation for oocyte donation using synthetic estrogen and progestogen.
Topics: Adult; Buserelin; Chorionic Gonadotropin; Dydrogesterone; Embryo Transfer; Endometrium; Estradiol; Estrogens, Conjugated (USP); Female; Humans; Menopause; Menotropins; Oocyte Donation; Ovarian Follicle; Pregnancy; Primary Ovarian Insufficiency; Progesterone Congeners; Ultrasonography | 1998 |
[Serum level of hCG-like substance in the patients of choriocarcinoma can be suppressed by Buserelin-administration].
Topics: Administration, Intranasal; Adult; Buserelin; Choriocarcinoma; Chorionic Gonadotropin; Drug Evaluation; Female; Humans; Menopause; Middle Aged; Pregnancy; Remission Induction; Uterine Neoplasms | 1992 |
Reversible menopause induced by the GnRH analogue buserelin: effects on lipoprotein metabolism.
Topics: Adult; Apolipoproteins A; Apolipoproteins B; Buserelin; Coronary Disease; Endometriosis; Female; Humans; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Menopause; Middle Aged; Radioimmunoassay; Risk Factors; Time Factors | 1992 |
Influence of tamoxifen, aminoglutethimide and goserelin on human plasma IGF-I levels in breast cancer patients.
Topics: Aminoglutethimide; Antineoplastic Agents; Breast Neoplasms; Buserelin; Cortisone; Female; Goserelin; Humans; Insulin-Like Growth Factor I; Menopause; Middle Aged; Tamoxifen | 1992 |
Comparison of two oestrogen receptor assays in the prediction of the clinical course of patients with advanced breast cancer.
Topics: Aged; Aging; Breast Neoplasms; Buserelin; Female; Goserelin; Humans; Immunoenzyme Techniques; Immunohistochemistry; Megestrol; Megestrol Acetate; Menopause; Middle Aged; Predictive Value of Tests; Prognosis; Receptors, Estrogen; Sensitivity and Specificity; Tamoxifen | 1992 |
Human prolactin release induced by follicle stimulating hormone, luteinizing hormone and human chorionic gonadotrophin.
Topics: Buserelin; Chorionic Gonadotropin; Clomiphene; Estradiol; Female; Fertilization in Vitro; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Menopause; Menotropins; Ovariectomy; Prolactin | 1991 |
[Buserelin therapy in postmenopausal patients with advanced breast carcinoma].
Topics: Adrenal Cortex Hormones; Adult; Aged; Breast Neoplasms; Buserelin; Estradiol; Female; Follicle Stimulating Hormone; Humans; Injections, Subcutaneous; Luteinizing Hormone; Menopause; Middle Aged; Prolactin; Testosterone; Thyroid Hormones | 1991 |
Hormone sensitivity in breast cancer: influence of heterogeneity of oestrogen receptor expression and cell proliferation.
Topics: Antibodies, Monoclonal; Breast Neoplasms; Buserelin; Cell Division; Female; Goserelin; Humans; Immunohistochemistry; Menopause; Predictive Value of Tests; Receptors, Estrogen; Tamoxifen | 1991 |
Calcium metabolism in premenopausal women treated by a Gn-RH agonist for uterine myoma.
Topics: Adult; Bone and Bones; Bone Density; Bone Resorption; Buserelin; Estradiol; Female; Humans; Leiomyoma; Menopause; Middle Aged; Osteoporosis; Receptors, LHRH; Uterine Neoplasms; Uterus | 1990 |
[Treatment of leiomyomas with luteinizing hormone-releasing hormone agonist].
Topics: Adult; Antigens, Tumor-Associated, Carbohydrate; Bone Density; Buserelin; Estradiol; Female; Follicle Stimulating Hormone; Follow-Up Studies; Humans; Leiomyoma; Luteinizing Hormone; Menopause; Menstruation; Middle Aged; Uterine Neoplasms | 1990 |
The ratios of serum bioactive/immunoreactive luteinizing hormone and follicle-stimulating hormone in various clinical conditions with increased and decreased gonadotropin secretion: reevaluation by a highly sensitive immunometric assay.
Topics: Adult; Aged; Biological Assay; Buserelin; Endometriosis; Female; Fluorescent Antibody Technique; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Goserelin; Humans; Luteinizing Hormone; Male; Menopause; Middle Aged; Nafarelin; Orchiectomy; Ovarian Neoplasms; Ovariectomy; Prostatic Neoplasms; Radioimmunoassay; Uterine Neoplasms | 1990 |
Estrogen deprivation in breast cancer. Clinical, experimental, and biological aspects.
Topics: Breast Neoplasms; Buserelin; Estradiol; Estrogen Antagonists; Female; Gonadotropin-Releasing Hormone; Goserelin; Humans; Menopause; Polyunsaturated Alkamides; Tamoxifen | 1990 |
Goserelin (Zoladex) in premenopausal advanced breast cancer: duration of response and survival.
Topics: Adult; Breast Neoplasms; Buserelin; Female; Goserelin; Humans; Menopause; Middle Aged; Receptors, Estrogen; Survival Rate; Time Factors | 1990 |
Zoladex: endocrine and therapeutic effects in post-menopausal breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Buserelin; Estradiol; Estrone; Female; Goserelin; Humans; Menopause; Middle Aged; Tamoxifen | 1989 |
Response to endocrine manipulation and oestrogen receptor concentration in large operable primary breast cancer.
Topics: Aminoglutethimide; Androstenedione; Breast Neoplasms; Buserelin; Female; Goserelin; Humans; Menopause; Receptors, Estrogen; Tamoxifen | 1989 |
Endocrinology of Zoladex in postmenopausal women.
Topics: Androgens; Breast Neoplasms; Buserelin; Delayed-Action Preparations; Estrogens; Female; Gonadotropins, Pituitary; Goserelin; Humans; Menopause | 1989 |
Zoladex: therapeutic effects in postmenopausal breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Buserelin; Estradiol; Estrone; Female; Goserelin; Humans; Menopause; Middle Aged | 1989 |
Clinical trials referral resource. Adjuvant therapy of breast cancer.
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Buserelin; Carcinoma in Situ; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Goserelin; Humans; Lymphatic Metastasis; Mastectomy, Segmental; Menopause; Middle Aged; Neoplasm Staging; Prognosis; Tamoxifen | 1989 |
A response in advanced post-menopausal breast cancer during treatment with the luteinising hormone releasing hormone agonist--Zoladex.
Topics: Aged; Breast Neoplasms; Buserelin; Carcinoma, Intraductal, Noninfiltrating; Female; Goserelin; Humans; Menopause | 1989 |
Endocrine and clinical effects of an LHRH analogue in pretreated advanced breast cancer.
Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Buserelin; Carcinoma, Intraductal, Noninfiltrating; Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Menopause; Middle Aged; Prolactin; Testosterone | 1988 |
Endocrinological and clinical aspects of LHRH action (ICI 118630) in hormone dependent breast cancer.
Topics: Adult; Breast Neoplasms; Buserelin; Estradiol; Female; Follicle Stimulating Hormone; Goserelin; Humans; Luteinizing Hormone; Menopause; Middle Aged; Neoplasms, Hormone-Dependent; Ovary; Pituitary Gland; Progesterone; Receptors, Estrogen; Time Factors | 1985 |
Preliminary endocrinological evaluation of a sustained-release formulation of the LH-releasing hormone agonist D-Ser(But)6Azgly10LHRH in premenopausal women with advanced breast cancer.
Topics: Breast Neoplasms; Buserelin; Delayed-Action Preparations; Estradiol; Female; Follicle Stimulating Hormone; Goserelin; Hormones; Humans; Luteinizing Hormone; Menopause; Middle Aged; Progesterone | 1986 |
Remission of postmenopausal breast cancer during treatment with the luteinising hormone releasing hormone agonist ICI 118630.
Topics: Adult; Aged; Bone Neoplasms; Breast Neoplasms; Buserelin; Female; Follicle Stimulating Hormone; Goserelin; Humans; Lung Neoplasms; Luteinizing Hormone; Menopause; Middle Aged; Remission Induction | 1986 |
Suppression of postmenopausal ovarian steroidogenesis with the luteinizing hormone-releasing hormone agonist goserelin.
Topics: Aged; Aged, 80 and over; Androgens; Breast Neoplasms; Buserelin; Estrogens; Female; Gonadotropins, Pituitary; Goserelin; Humans; Menopause; Middle Aged; Ovary | 1988 |
Effect of LHRH agonist, Zoladex, on ovarian histology.
Topics: Breast Neoplasms; Buserelin; Drug Evaluation; Female; Goserelin; Humans; Menopause; Ovariectomy; Ovary | 1988 |
Treatment of breast cancer with gonadotropin-releasing hormone.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Buserelin; Delayed-Action Preparations; Estrogens; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Luteinizing Hormone; Menopause; Menstruation; Middle Aged; Tamoxifen | 1986 |
Hypogonadism induced by luteinising hormone releasing hormone agonist analogues: effects on bone density in premenopausal women.
Topics: Absorptiometry, Photon; Adult; Bone and Bones; Buserelin; Female; Femur; Humans; Hypogonadism; Lumbar Vertebrae; Menopause; Tomography, X-Ray Computed | 1987 |
The treatment of postmenopausal women with advanced breast cancer with buserelin.
Topics: Adenocarcinoma; Aged; Breast Neoplasms; Buserelin; Female; Gonadotropins, Pituitary; Humans; Hypophysectomy, Chemical; Lymphatic Metastasis; Menopause; Middle Aged; Time Factors | 1985 |
Effect of an intranasal LHRH agonist on gonadotrophins and hot flushes in post-menopausal women.
Topics: Administration, Intranasal; Adult; Buserelin; Female; Flushing; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Gonadotropins; Humans; Luteinizing Hormone; Menopause; Middle Aged | 1985 |